Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Reeh

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Digestive Surgery|November 28, 2019
Surgical Management of Non-Malignant Esophageal Perforations: A Single-Center Analysis Over a 15-Year PeriodKarl-Frederick Karstens, Eugen Bellon, Michael Tachezy, et al.
Medicine|February 18, 2016
The PER (Preoperative Esophagectomy Risk) Score: A Simple Risk Score to Predict Short-Term and Long-Term Outcome in Patients with Surgically Treated Esophageal CancerMatthias Reeh, Johannes Metze, Faik G Uzunoglu, et al.
Scientific Reports|July 5, 2023
Minimally invasive intrathoracic negative-pressure therapy and flexible thoracoscopy (FlexVATS) for patients with pleural empyemaBjörn-Ole Stüben, Gabriel A Plitzko, Julia Sauerbeck, et al.
Scientific Reports|May 7, 2026
PD-L1-positive circulating tumor cells associate with tumor malignancy and impaired circulating immunity in patients with gastrointestinal tumorsLeon Jonathan Kusterer, Matthias Reeh, Yogesh Kumar, et al.
Experimental and Molecular Pathology|February 2, 2019
High levels of RAI3 expression is linked to shortened survival in esophageal cancer patientsAlexander Tarek El Gammal, Nathaniel Melling, Matthias Reeh, et al.
Annals of Surgery|June 13, 2019
Prospective Comparison of the Prognostic Relevance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow of a Single Patient's Cohort With Esophageal CancerLeonie Konczalla, Tarik Ghadban, Katharina E Effenberger, et al.
International Journal of Cancer|September 21, 2011
Disseminated tumor cells in pancreatic cancer-an independent prognosticator of disease progression and survivalKatharina E Effenberger, Cornelia Schroeder, Christine Eulenburg, et al.
World Journal of Surgery|September 23, 2011
Multivisceral resections in pancreatic cancer: identification of risk factorsChristoph M Burdelski, Matthias Reeh, Dean Bogoevski, et al.
Cancers|February 25, 2022
Completion of FLOT Therapy, Regardless of Tumor Regression, Significantly Improves Overall Survival in Patients with Esophageal AdenocarcinomaBjörn-Ole Stüben, Jakob Stuhlfelder, Marius Kemper, et al.
Clinical Chemistry|November 9, 2012
Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancerChristin Gasch, Thomas Bauernhofer, Martin Pichler, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Digestive Surgery|November 28, 2019
Surgical Management of Non-Malignant Esophageal Perforations: A Single-Center Analysis Over a 15-Year PeriodKarl-Frederick Karstens, Eugen Bellon, Michael Tachezy, et al.
Medicine|February 18, 2016
The PER (Preoperative Esophagectomy Risk) Score: A Simple Risk Score to Predict Short-Term and Long-Term Outcome in Patients with Surgically Treated Esophageal CancerMatthias Reeh, Johannes Metze, Faik G Uzunoglu, et al.
Scientific Reports|July 5, 2023
Minimally invasive intrathoracic negative-pressure therapy and flexible thoracoscopy (FlexVATS) for patients with pleural empyemaBjörn-Ole Stüben, Gabriel A Plitzko, Julia Sauerbeck, et al.
Scientific Reports|May 7, 2026
PD-L1-positive circulating tumor cells associate with tumor malignancy and impaired circulating immunity in patients with gastrointestinal tumorsLeon Jonathan Kusterer, Matthias Reeh, Yogesh Kumar, et al.
Experimental and Molecular Pathology|February 2, 2019
High levels of RAI3 expression is linked to shortened survival in esophageal cancer patientsAlexander Tarek El Gammal, Nathaniel Melling, Matthias Reeh, et al.
Annals of Surgery|June 13, 2019
Prospective Comparison of the Prognostic Relevance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow of a Single Patient's Cohort With Esophageal CancerLeonie Konczalla, Tarik Ghadban, Katharina E Effenberger, et al.
International Journal of Cancer|September 21, 2011
Disseminated tumor cells in pancreatic cancer-an independent prognosticator of disease progression and survivalKatharina E Effenberger, Cornelia Schroeder, Christine Eulenburg, et al.
World Journal of Surgery|September 23, 2011
Multivisceral resections in pancreatic cancer: identification of risk factorsChristoph M Burdelski, Matthias Reeh, Dean Bogoevski, et al.
Cancers|February 25, 2022
Completion of FLOT Therapy, Regardless of Tumor Regression, Significantly Improves Overall Survival in Patients with Esophageal AdenocarcinomaBjörn-Ole Stüben, Jakob Stuhlfelder, Marius Kemper, et al.
Clinical Chemistry|November 9, 2012
Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancerChristin Gasch, Thomas Bauernhofer, Martin Pichler, et al.
Pageof 11